Skip to main content

Advertisement

Figure 2 | BMC Infectious Diseases

Figure 2

From: Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

Figure 2

Kaplan-Meier estimates of the risk of ALT elevation (A) and Fib-4 elevation (B) according to sCD14 strata. Kaplan-Meier plots were used to compare the cumulative percent of patients reaching the primary endpoint. The cohort was stratified according to sCD14 plasma levels above or below the median (i.e. 3.6 pg/ml).

Back to article page